31 results on '"Helin, H J"'
Search Results
2. Influence of endocrine status on biochemical and immunocytochemical estrogen and progesterone receptor assays in breast cancer patients
- Author
-
Helin, H. J., Isola, J. J., Helle, M. J., and Adlercreutz, H.
- Published
- 1988
- Full Text
- View/download PDF
3. Identification of germline MLH1 alterations in familial prostate cancer.
- Author
-
Fredriksson, H, Ikonen, T, Autio, V, Matikainen, M P, Helin, H J, Tammela, T L J, Koivisto, P A, Schleutker, J, Fredriksson, H, Ikonen, T, Autio, V, Matikainen, M P, Helin, H J, Tammela, T L J, Koivisto, P A, and Schleutker, J
- Published
- 2006
4. Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis
- Author
-
Sallinen, P. K., primary, Sallinen, S. ‐L., additional, Helén, P. T., additional, Rantala, I. S., additional, Rautiainen, E., additional, Helin, H. J., additional, Kalimo, H., additional, and Haapasalo, H. K., additional
- Published
- 2000
- Full Text
- View/download PDF
5. Immunological reactions to liver-specific membrane lipoprotein (LSP) in experimental autoimmune liver diseasi in rabbits.
- Author
-
Uibo, R. M., Helin, H. J., and Krohn, K. J. E.
- Subjects
- *
ABDOMEN , *BILIARY tract , *IMMUNOGLOBULINS , *CELLULAR immunity , *LIVER diseases , *IMMUNIZATION - Abstract
Humoral and cellular immunity to a liver-specific membrane lipoprotein (LSP) was followed in rabbits immunized either with allogenic rabbit LSP (RLSP) or with xenogenic human (HLSP) or bovine (BLSP) antigens. After 4 months of immunization, all rabbits showed histoiogical changes in liver resembling those found in chronic aggressive hepatitis and occasionally also those seen in primary biliary cirrhosis in man. Antibodies reacting to both allogenic as well as xenogeneic LSP preparations were found with an enzyme-linked solid phase immunosorbents assay (F.LISA) in all immunized rabbits. Lymphocyte transformation tests in unionized rabbits showed an occasional response to some of the LSP preparations and a strong response towards an equivalent rabbit kidney preparation (RKSP). After immunization, reactions to LSP preparations increased significantly, while no response to RKSP was observed. The results confirm previous findings and further demonstrate that similar LSP containing preparations from human, bovine and rabbit sources share auto antigenic. liver-specific determinants. In addition, species specific determinants seem to be present in each of the LSP preparations studied. [ABSTRACT FROM AUTHOR]
- Published
- 1982
6. Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count.
- Author
-
Isola, Jorma J., Helin, Heikki J., Helle, Markku J., Kallioniemi, Olli-Pekka, Isola, J J, Helin, H J, Helle, M J, and Kallioniemi, O P
- Published
- 1990
- Full Text
- View/download PDF
7. Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and DNA flow cytometry.
- Author
-
Helin, Heikki J., Helle, Markku J., Kallioniemi, Olli-Pekka, Isola, Jorma J., Helin, H J, Helle, M J, Kallioniemi, O P, and Isola, J J
- Published
- 1989
- Full Text
- View/download PDF
8. Imprint cytology in immunocytochemical analysis of oestrogen and progesterone receptors of breast carcinoma.
- Author
-
Helin, H J, Isola, J J, Helin, M J, Helle, M J, and Krohn, K J
- Abstract
Cytological imprint material from 26 mammary carcinomas was stained with monoclonal antibodies to oestrogen and progesterone receptors in an immunoperoxidase procedure. The staining result was compared with that of parallel stainings of frozen tissue sections of the same tumours. The peroxidase reactions in both techniques were semiquantitatively assessed (histoscore). In both sets of stainings the results agreed in 25 of 26 cases (oestrogen receptor: 19 positive, six negative; progesterone receptor: 14 positive, 11 negative). The histoscores of imprint preparations and cryostat sections showed a significant correlation in linear regression analysis (oestrogen receptor: r = 0.755, p less than 0.001; progesterone receptor: r = 0.740, p less than 0.001). Imprint cytology is simple, does not require expensive instruments, and no separate specimen has to be sequestered. It is especially suitable for immunocytochemical steroid receptor analysis of small breast carcinomas. [ABSTRACT FROM PUBLISHER]
- Published
- 1989
- Full Text
- View/download PDF
9. Cyclosporin A regulates monocyte/macrophage effector functions by affecting instructor T cells: inhibition of monocyte procoagulant response to allogeneic stimulation.
- Author
-
Helin, H J, primary and Edgington, T S, additional
- Published
- 1984
- Full Text
- View/download PDF
10. The instructor cell for the human procoagulant monocyte response to bacterial lipopolysaccharide is a Leu-3a+ T cell by fluorescence-activated cell sorting.
- Author
-
Helin, H J, primary, Fox, R I, additional, and Edgington, T S, additional
- Published
- 1983
- Full Text
- View/download PDF
11. Identification of germline MLH1 alterations in familial prostate cancer.
- Author
-
Fredriksson H, Ikonen T, Autio V, Matikainen MP, Helin HJ, Tammela TL, Koivisto PA, and Schleutker J
- Subjects
- Adaptor Proteins, Signal Transducing, Adult, Aged, Aged, 80 and over, Humans, Immunohistochemistry, Male, Middle Aged, MutL Protein Homolog 1, Pedigree, Registries, Carrier Proteins genetics, Germ-Line Mutation genetics, Mutation, Missense genetics, Nuclear Proteins genetics, Prostatic Neoplasms genetics
- Abstract
Several linkage and loss of heterozygosity (LOH) analyses suggest that the region 3p21-p26, which is a chromosomal location of MLH1, could harbour a susceptibility gene for prostate cancer (PRCA). Furthermore, in a recent candidate single nucleotide polymorphism (SNP) analysis the I219V variation of the MLH1 gene was associated with PRCA. Microsatellite instability (MSI) and germ-line MLH1 mutations were originally demonstrated in hereditary non-polyposis colorectal cancer (HNPCC) but MSI and loss of MLH1 function have also been detected in PRCA. To assess the contribution of MLH1 germline mutations to the development of PRCA in Finland different approaches were used. First, the samples from 11 PRCA-colon cancer patients were screened for MLH1, MSH2 and MSH6 protein expression by immunohistochemistry (IHC). IHC revealed one patient with a putative MLH1 aberration and sequencing of this sample revealed five sequence variants including two missense variants P434L and I219V. Second, the samples from Finnish hereditary prostate cancer (HPC) families were used for the screening of MLH1 mutations which produced twelve MLH1 sequence variants including two missense mutations, I219V, as in the PRCA-colon cancer patient, and V647M. P434L and V647 were both novel, rare variants. Carrier frequencies of the I219V mutation were compared between hereditary prostate cancer (HPC) patients, unselected PRCA cases, patients with benign prostate hyperplasia and controls, but no differences between the sample groups were found. P434L was not present in this study population and V647M was a very rare variant found only in one HPC family. According to the present results, MLH1 does not have a major role in PRCA causation in Finland.
- Published
- 2006
- Full Text
- View/download PDF
12. Androgen receptor alterations in prostate cancer relapsed during a combined androgen blockade by orchiectomy and bicalutamide.
- Author
-
Haapala K, Hyytinen ER, Roiha M, Laurila M, Rantala I, Helin HJ, and Koivisto PA
- Subjects
- Combined Modality Therapy, Humans, Male, Neoplasm Recurrence, Local, Nitriles, Tosyl Compounds, Androgen Antagonists therapeutic use, Anilides therapeutic use, Mutation, Orchiectomy, Prostatic Neoplasms genetics, Prostatic Neoplasms therapy, Receptors, Androgen genetics
- Abstract
Mechanisms of prostate cancer (CaP) recurrence during a combined androgen blockade (CAB) are poorly understood. Previously, the role of androgen receptor (AR) gene mutations underlying the CAB therapy relapse has been raised. To investigate the hypothesis that AR gene aberrations are involved in CAB relapse, 11 locally recurrent CaP samples from patients treated with orchiectomy and bicalutamide were analyzed for copy number changes and DNA sequence alterations of the AR gene by fluorescence in situ hybridization and single-strand conformation polymorphism, respectively. Altogether, base changes were detected in four tumors (36%). Three of them were missense mutations (G166S, W741C, M749I) and two were silent polymorphisms. Interestingly, none of the tumors had AR amplification. These data suggest that different AR variants are developed and selected for during various types of hormonal treatments, and also, that CAB achieved by orchiectomy and bicalutamide does not act as a selective force for AR amplification.
- Published
- 2001
- Full Text
- View/download PDF
13. Association of E-cadherin germ-line alterations with prostate cancer.
- Author
-
Ikonen T, Matikainen M, Mononen N, Hyytinen ER, Helin HJ, Tommola S, Tammela TL, Pukkala E, Schleutker J, Kallioniemi OP, and Koivisto PA
- Subjects
- Adaptor Proteins, Signal Transducing, Aged, Aged, 80 and over, Carrier Proteins, Colorectal Neoplasms, Hereditary Nonpolyposis genetics, DNA Mutational Analysis, DNA, Neoplasm chemistry, DNA, Neoplasm genetics, Family Health, Female, Genetic Testing, Humans, Male, MutL Protein Homolog 1, Mutation, Mutation, Missense, Neoplasm Proteins genetics, Nuclear Proteins, Pedigree, Prostatic Neoplasms diagnosis, Stomach Neoplasms genetics, Cadherins genetics, Germ-Line Mutation, Prostatic Neoplasms genetics
- Abstract
In our recent cancer registry-based study, the incidence of gastric carcinoma was increased up to 5-fold in male relatives of early-onset prostate cancer (PCA) patients. This association may reflect the influence of genetic factors predisposing individuals to both tumor types. Germ-line mutations of the CDH1 gene at 16q have recently been associated with familial gastric cancer. Furthermore, two genome-wide linkage studies of PCA recently reported positivity at 16q. We therefore identified families and individual patients with both gastric and PCA and investigated whether the CDH1 gene mutations were involved in cancer predisposition in these cases. Fifteen of the 180 Finnish hereditary PCA families (8.3%) had one or more gastric cancer cases. No truncating or splice site CDH1 mutations were identified by PCR single-strand conformational polymorphism in these families or in eight individual patients who had both prostate and gastric cancer. However, a novel S270A missense mutation in exon 6 of the CDH1 gene was seen in a single family with four prostate and two gastric cancers. A large-scale population-based survey indicated a higher prevalence of S270A among both familial PCA cases (3.3%; n = 120; P = 0.01) and unselected PCA patients (1.5%; n = 472; P = 0.12) as compared with blood donors serving as population controls (0.5%; n = 923). We conclude that individual rare mutations and polymorphisms in the CDH1 gene, such as S270A, may contribute to the onset of PCA and warrant further investigations in other populations. However, the CDH1 gene does not appear to explain the link between prostate and gastric cancer.
- Published
- 2001
14. Genetic changes in familial prostate cancer by comparative genomic hybridization.
- Author
-
Rökman A, Koivisto PA, Matikainen MP, Kuukasjärvi T, Poutiainen M, Helin HJ, Karhu R, Kallioniemi OP, and Schleutker J
- Subjects
- Aged, Aged, 80 and over, Chromosome Aberrations, Genetic Predisposition to Disease genetics, Humans, Karyotyping, Male, Middle Aged, Nucleic Acid Hybridization, Carcinoma genetics, Prostatic Neoplasms genetics
- Abstract
Background: Germline mutations in recessive cancer predisposition genes are uncovered by somatic genetic deletions during tumor development. Analysis of genetic changes in tumor tissues from patients with an inherited predisposition may therefore highlight regions of the genome containing susceptibility or modifier genes. Our aim was to characterize genetic changes in familial prostate cancer, Methods: Twenty-one primary prostate cancers from 19 Finnish prostate cancer families were analyzed for somatic genetic changes by comparative genomic hybridization (CGH)., Results: The average number of genetic alterations per tumor was 4.0 +/- 1.9, distributed equally among losses and gains. The most common losses were found at chromosomal regions 13q14-q22 (29%), 8p12-pter (24%), and 6q13-q16 (14%), and the most common gains at 19p (25%), 19q (14%) and 7q (14%)., Conclusions: These results suggest that prostate cancers in genetically predisposed individuals arise for the most part through similar somatic genetic progression pathways as sporadic prostate cancers. This also implies that the biological properties of tumors from the two groups may not be different from one another., (Copyright 2001 Wiley-Liss, Inc.)
- Published
- 2001
- Full Text
- View/download PDF
15. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques.
- Author
-
Sallinen SL, Sallinen PK, Haapasalo HK, Helin HJ, Helén PT, Schraml P, Kallioniemi OP, and Kononen J
- Subjects
- Astrocytoma metabolism, Astrocytoma pathology, Brain Neoplasms metabolism, Brain Neoplasms pathology, Disease Progression, Gene Expression Regulation, Neoplastic, Glioblastoma metabolism, Glioblastoma pathology, Humans, Insulin-Like Growth Factor Binding Protein 2 biosynthesis, Insulin-Like Growth Factor Binding Protein 2 genetics, Up-Regulation, Astrocytoma genetics, Brain Neoplasms genetics, Gene Expression Profiling methods, Glioblastoma genetics, Oligonucleotide Array Sequence Analysis methods
- Abstract
New genomic large-scale screening techniques have made the task of establishing an accurate molecular fingerprint of cancer cells feasible. Here, we have used a two-phase strategy for identification of molecular alterations in gliomas. First, cDNA microarrays (Clontech Laboratories, Inc., Research Genetics) were used to pinpoint differentially expressed genes between normal brain and diffuse astrocytomas (grades II-IV), and between a primary tumor and a later tumor reoccurrence in the same patient. More than 200 gene expression alterations were detected from glioblastomas, whereas relatively few changes were seen in grade II and grade III tumors. The most distinct progression-related expression change was the up-regulation of the insulin-like growth factor binding protein 2 (IGFBP2) gene. Second, a high-density tissue microarray of 418 brain tumors was constructed and used for clinical validation of gene expression changes. Strong expression of IGFBP2 was associated with progression and poor patient survival in diffuse astrocytomas (P < 0.0001). Third, comparisons of the data between (a) multiple spots retrieved from one predefined tumor region (IGFBP2 and vimentin immunohistochemistry, 20 tumors) or between (b) standard slides and arrayed tissues (p53 immunohistochemistry, 42 tumors) revealed very little variation. In conclusion, the combined use of DNA microarrays and tissue microarrays offers a powerful strategy for rapid identification and thorough characterization of differentially expressed genes in gliomas.
- Published
- 2000
16. Androgen receptor gene amplification increases tissue PSA protein expression in hormone-refractory prostate carcinoma.
- Author
-
Koivisto PA and Helin HJ
- Subjects
- Gene Amplification, Humans, Immunoenzyme Techniques, In Situ Hybridization, Fluorescence, Male, Neoplasm Recurrence, Local metabolism, Neoplasm Recurrence, Local therapy, Prostatic Neoplasms metabolism, Prostatic Neoplasms therapy, Treatment Failure, Biomarkers, Tumor metabolism, Neoplasm Recurrence, Local genetics, Prostate-Specific Antigen metabolism, Prostatic Neoplasms genetics, Receptors, Androgen genetics
- Abstract
Androgen receptor (AR) gene amplification was analysed by fluorescence in situ hybridization (FISH) from 24 paraffin-embedded prostate carcinoma samples recurring locally during hormonal therapy and prostate-specific antigen (PSA) expression from 15/24 of these samples was studied by immunohistochemistry (IHC). AR gene amplification was detected in 29 per cent (7/24) of the recurrent tumours. Using modified Histoscore (MHS), PSA immunostaining in the AR gene-amplified tumours (133+/-102) was twice as high (p=0.054) as in tumours with no amplification (66+/-79) and a statistically significant (p=0.026) association between AR gene amplification and PSA positivity was found when MHS>/=20 was considered positive for PSA. AR gene copy number was positively correlated with PSA MHS in the AR gene-amplified tumours (r=0.893, p=0.012). Histological grade, Gleason's score, and tumour stage did not differ significantly between patients with and without AR gene amplification. In conclusion, these results indicate that AR gene amplification leads to up-regulation of PSA gene (and possibly other androgen-dependent genes), and that patients with AR gene amplification may have elevated serum PSA concentrations without a clear correlation with actual tumour burden., (Copyright 1999 John Wiley & Sons, Ltd.)
- Published
- 1999
- Full Text
- View/download PDF
17. Cyclin D1 expression in astrocytomas is associated with cell proliferation activity and patient prognosis.
- Author
-
Sallinen SL, Sallinen PK, Kononen JT, Syrjäkoski KM, Nupponen NN, Rantala IS, Helén PT, Helin HJ, and Haapasalo HK
- Subjects
- Astrocytoma pathology, Cell Division, Cyclin D1 genetics, Follow-Up Studies, Gene Expression, Humans, Prognosis, RNA, Messenger genetics, RNA, Neoplasm genetics, Survival Rate, Astrocytoma metabolism, Biomarkers, Tumor metabolism, Cyclin D1 metabolism, Neoplasm Proteins metabolism
- Abstract
An important positive regulator of the cell cycle, cyclin D1, is often amplified and overexpressed in malignancies. Cyclin D1 aberrations were analysed in grade II-IV astrocytomas by fluorescence in situ hybridization (FISH), mRNA in situ hybridization and immunohistochemistry. Proliferation activity was determined by Ki-67(MIB-1) immunolabelling and mitotic counting. High cyclin D1 expression was observed in grade IV astrocytomas (grades II-III versus grade IV; mRNA expression: p<0.001; immunoexpression: p=0.013), and correlated with poor patient survival (p<0.001, n=46). Upregulated cyclin D1 expression was also closely associated with poor patient prognosis in grade II-III astrocytomas (p<0.001, n=30). Cyclin D1 gene was not found to be amplified (n=7). Cell proliferation activity was significantly increased in tumours exhibiting high cyclin D1 mRNA levels (Ki-67(MIB-1): p<0.001; mitotic count: p<0.001) and high cyclin D1 protein expression (Ki-67(MIB-1): p=0.002; mitotic count: p=0.012). These results indicate that increased production of cyclin D1 is closely associated with high cell proliferation activity and aggressive behaviour in diffusely infiltrating astrocytomas., (Copyright 1999 John Wiley & Sons, Ltd.)
- Published
- 1999
- Full Text
- View/download PDF
18. Cytoplasmic accumulation of alpha-catenin is associated with aggressive features in laryngeal squamous-cell carcinoma.
- Author
-
Hirvikoski P, Kumpulainen EJ, Virtaniemi JA, Helin HJ, Rantala I, Johansson RT, Juhola M, and Kosma VM
- Subjects
- Adult, Aged, Aged, 80 and over, Cadherins metabolism, Carcinoma, Squamous Cell mortality, Carcinoma, Squamous Cell pathology, Cytoskeletal Proteins analysis, Disease-Free Survival, Female, Humans, Immunohistochemistry, Laryngeal Neoplasms mortality, Laryngeal Neoplasms pathology, Male, Middle Aged, Neoplasm Metastasis, Neoplasm Staging, Prognosis, Tissue Embedding, alpha Catenin, Carcinoma, Squamous Cell metabolism, Cytoplasm metabolism, Cytoskeletal Proteins metabolism, Laryngeal Neoplasms metabolism
- Abstract
Aberrations in the function of alpha-catenin (alpha-cat), the anchoring protein of E-cadherin, are believed to cause dysfunction of the cadherin-catenin complex, leading to disturbed cell-cell adhesion. It has been suggested that expression of alpha-cat in human tumours might be a better indicator of aggressive phenotype than expression of E-cadherin. The value of alpha-cat as a prognostic marker in laryngeal squamous cell carcinoma (LSCC) is unclear. To determine the potential prognostic significance of alpha-cat, paraffin-embedded samples from 159 patients with invasive carcinoma left in the section and with long-term follow-up were evaluated immuno-histochemically for alpha-cat expression, and the results were related to histopathological grade, tumour stage and survival. Two patterns of staining were observed: pure membranous staining (57%) and membranous staining with cytoplasmic involvement (43%). Cytoplasmic involvement of alpha-cat was associated with dedifferentiation, advanced tumour stage and nodal status. In addition, supra-glottic tumours showed more often cytoplasmic involvement of alpha-cat than glottic tumours. Patients with cytoplasmic involvement appeared to have a trend towards poor overall survival, though without statistical significance. These results suggest that cytoplasmic involvement of alpha-cat is associated with aggressive behaviour and metastatic phenotype of LSCC.
- Published
- 1998
- Full Text
- View/download PDF
19. Age-related appearance of amyloid P component in human renal glomeruli.
- Author
-
Rantala IS, Helin HJ, Mustonen JT, and Reunala T
- Subjects
- Adolescent, Adult, Aging metabolism, Child, Female, Humans, Kidney Cortex metabolism, Male, Middle Aged, Kidney Glomerulus metabolism, Serum Amyloid P-Component metabolism
- Abstract
Amyloid P component (AP) is a matrix glycoprotein of adult renal glomeruli. To establish whether the deposition of AP in glomeruli is an age-related phenomenon, this study used indirect immunofluorescence (IF) to investigate 34 renal biopsy specimens and 11 renal autopsy specimens. The biopsy specimens were taken from 9 patients (age range from 2 to 38 years) with normal glomerular morphology and from 25 patients (age range from 4 to 56 years) with various renal diseases. All autopsy specimens (age range form 2 months to 28 years) showed normal glomerular morphology. AP was not detected in glomeruli before age 6. By age 14, the IF intensity reached the level of the adult specimens, in which a strong fluorescence was seen along the basement membranes and within the mesangial matrix. In renal diseases, glomerular AP also appeared after age 6, although varying in its location and intensity. In conclusion, our results indicate that the appearance of AP in glomeruli is an age-related phenomenon, the pattern of which varies in renal diseases.
- Published
- 1997
- Full Text
- View/download PDF
20. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer.
- Author
-
Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA, and Isola JJ
- Subjects
- Adult, Aged, Antibodies, Monoclonal, Breast Neoplasms chemistry, Breast Neoplasms metabolism, Carcinoma, Ductal, Breast chemistry, Carcinoma, Ductal, Breast metabolism, Carcinoma, Ductal, Breast pathology, Carcinoma, Intraductal, Noninfiltrating chemistry, Carcinoma, Intraductal, Noninfiltrating metabolism, Carcinoma, Intraductal, Noninfiltrating pathology, Carcinoma, Lobular chemistry, Carcinoma, Lobular metabolism, Carcinoma, Lobular pathology, Disease-Free Survival, Female, Humans, Immunohistochemistry, In Situ Hybridization, Middle Aged, Neoplasm Invasiveness, Prognosis, RNA, Neoplasm analysis, Receptors, Estrogen analysis, Receptors, Progesterone analysis, Breast Neoplasms pathology, Cadherins biosynthesis
- Abstract
E-cadherin (E-cad) is a calcium-dependent, epithelial cell adhesion molecule whose reduced or lost expression has been associated with tumor dedifferentiation and increased metastatic potential in human carcinomas. The authors studied immunohistochemically E-cad expression in frozen sections of 362 breast carcinomas using a monoclonal antibody (HECD-1). The immunohistochemical detection of reduced E-cad expression was confirmed by mRNA in situ hybridization with two different oligonucleotide probes. THe proportion of tumors with reduced or lost E-cad expression increased significantly from pure intraductal carcinomas (20%, 4 of 20) through invasive ductal (IDCs; 52%, 124 of 239) to recurrent carcinomas (64%, 18 of 28; chi square test for trend, P = .004). Invasive lobular carcinomas (ILCs) and IDCs differed from each other in their E-cad expression. None of the ILCs (n=55) retained normal E-cad expression in contrast to 48% (115 of 239) of the IDCs. In 259 primary IDCs, reduced E-cad expression was associated with high histologic grade (chi square test for trend, P < .001), negative estrogen receptor status (ER; Fisher's exact test; P = .042), and marginally with axillary node involvement (Fisher's exact test, P = .063). In a subset of 109 primary IDC patients whose clinical follow-up was available (median follow-up 51 months), reduced E-cad expression was associated with shortened disease-free survival (DFS; Mantel-Cox test, P = .027). In Cox's multivariate regression analysis, progesterone receptor status (P = .018) and E-cad expression (P = .072) were selected as independent predictors of DFS. Our findings provide clinical evidence that loss of normal E-cad expression is an indicator of increased invasiveness and dedifferentiation in breast carcinoma. E-cad is a potentially important prognostic factor in primary IDCs.
- Published
- 1996
- Full Text
- View/download PDF
21. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas.
- Author
-
Siitonen SM, Haapasalo HK, Rantala IS, Helin HJ, and Isola JJ
- Subjects
- Adult, Aged, Aged, 80 and over, Antigens, CD34 analysis, Antigens, Differentiation, Myelomonocytic analysis, Breast Neoplasms immunology, Breast Neoplasms pathology, Cell Adhesion Molecules analysis, Endothelium, Vascular immunology, Endothelium, Vascular pathology, Female, Humans, Middle Aged, Platelet Endothelial Cell Adhesion Molecule-1, Prognosis, Retrospective Studies, Survival Analysis, von Willebrand Factor analysis, Breast Neoplasms blood supply, Immunoenzyme Techniques, Neovascularization, Pathologic pathology
- Abstract
There is evidence that tumor angiogenesis, as detected by immunohistochemical staining of endothelium, is of prognostic significance in breast cancer. However, little attention has been paid to possible differences between antibodies or to quantitation of the stained microvessels. We compared three endothelial cell antibodies [anti-human von Willebrand factor (anti-VWF, also termed factor VIII), anti-CD31, and anti-CD34] in archival paraffin-embedded specimens. Anti-CD34 and anti-VWF showed better staining performances than anti-CD31, although the staining results with different antibodies were comparable. Two different methods of microvessel quantitation (the highest microvessel count and percentage microvessel area) were evaluated and also showed significant correlation. From a retrospective database (n = 1000), 77 axillary node-negative invasive ductal breast carcinomas were selected on the basis of clinical outcome to maximize the prognostic power of the sample set (37 died due to a metastatic breast carcinoma, 40 showed no recurrence during 8-yr follow-up). Microvessel quantitations were related to flow cytometric DNA ploidy, c-erb-B-2 overexpression, and estrogen receptor status of the tumor. Surprisingly, neither highest microvessel counts nor microvessel area measurements quantitated with anti-CD34 or anti-VWF immunohistochemistry were able to discriminate between favorable and unfavorable outcome patients. Thus, our results suggest that further evidence is still needed on tumor angiogenesis immunohistochemistry before it can be adopted as a prognostic marker in routine, clinical practice.
- Published
- 1995
22. Occurrence of late specific complications in type II (non-insulin-dependent) diabetes mellitus.
- Author
-
Wirta OR, Pasternack AI, Oksa HH, Mustonen JT, Koivula TA, Helin HJ, and Lähde YE
- Subjects
- Albuminuria epidemiology, Analysis of Variance, Blood Glucose metabolism, Blood Pressure, Cross-Sectional Studies, Diabetic Nephropathies physiopathology, Diabetic Neuropathies physiopathology, Diabetic Retinopathy physiopathology, Female, Finland, Glomerular Filtration Rate, Glycated Hemoglobin analysis, Humans, Insulin blood, Male, Middle Aged, Reference Values, Regression Analysis, Time Factors, Valsalva Maneuver, Diabetes Mellitus, Type 2 physiopathology, Diabetic Nephropathies epidemiology, Diabetic Neuropathies epidemiology, Diabetic Retinopathy epidemiology
- Abstract
The objective of the present study was to determine the occurrence of late specific complications, i.e., nephropathy, retinopathy, and autonomic neuropathy, in type II (non-insulin-dependent) diabetic subjects with a recent onset and with a disease duration of at least 5 years. The study design comprised of a population-based controlled cross-sectional survey of middle-aged type II diabetic subjects in the City of Tampere, Southwest Finland. The mean (SD) albumin excretion rate per 24 h was found to have increased in recently diagnosed diabetic subjects, i.e., 54 (111) mg (p < 0.0001), and in long-term diabetic subjects, 134 (479) mg (p < 0.0001), compared to nondiabetic controls, 16 (19) mg. Microalbuminuria (30 mg/24 h < or = albumin excretion rate < or = 300 mg/24 h) was detected in 8% of nondiabetic subjects and in 29% of recently diagnosed subjects and 27% of long-term diabetic subjects. The prevalence of clinical nephropathy (albumin excretion rate > 300 mg/24 h) was 7% in long-term and 4% in recently diagnosed diabetic subjects and zero in nondiabetic subjects. The differences between diabetic and nondiabetic subjects tested for microalbuminuria and clinical nephropathy were significant (p = 0.02-0.0001) exempting the difference between recently diagnosed female diabetic subjects and nondiabetic female subjects tested for clinical nephropathy. Seventy-five percent of biopsied diabetic subjects with an albumin excretion rate exceeding 100 mg/24 h were found to have diabetic glomerulosclerosis, while the rest had a normal finding. In long-term diabetic subjects the prevalence of nonspecific, background and proliferative retinopathies were present in 40%, 31%, and 8%, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1995
- Full Text
- View/download PDF
23. Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis.
- Author
-
Helin HJ, Korpela MM, Mustonen JT, and Pasternack AI
- Subjects
- Adolescent, Adult, Aged, Amyloidosis pathology, Biopsy, Child, Female, Glomerulonephritis, Membranoproliferative pathology, Glomerulonephritis, Membranous pathology, Glomerulosclerosis, Focal Segmental pathology, Humans, Kidney Diseases pathology, Male, Middle Aged, Nephritis, Interstitial pathology, Nephrosis, Lipoid pathology, Prognosis, Arthritis, Rheumatoid pathology, Kidney pathology
- Abstract
Objective: To evaluate renal biopsy findings and clinicopathologic correlations in patients with rheumatoid arthritis (RA)., Methods: Retrospective study of renal biopsy specimens from 110 RA patients in whom the clinical renal disease was probably due to RA itself and/or to antirheumatic therapy., Results: The most common histopathologic finding was mesangial glomerulonephritis (GN) (n = 40), followed by amyloidosis (n = 33), membranous GN (n = 19), focal proliferative GN (n = 4), minimal-change nephropathy (n = 3), and acute interstitial nephritis (n = 1). Amyloidosis was the most common finding in patients with the nephrotic syndrome. In patients with isolated proteinuria, amyloidosis, membranous GN, and mesangial GN were almost equally common. Although mesangial GN was found in almost two-thirds of the RA patients with hematuria (with or without proteinuria), there still remained a 1 in 5 chance that the biopsy would reveal membranous GN or amyloidosis. Membranous GN was closely related to gold or D-penicillamine therapies, whereas mesangial GN probably related to RA itself., Conclusion: The renal morphologic lesion in RA patients with isolated proteinuria and those with hematuria cannot be accurately predicted on the basis of clinical symptoms and signs. Biopsy is thus useful in differential diagnosis, assessment of prognosis, and decision-making with regard to treatment.
- Published
- 1995
- Full Text
- View/download PDF
24. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples.
- Author
-
Sallinen PK, Haapasalo HK, Visakorpi T, Helén PT, Rantala IS, Isola JJ, and Helin HJ
- Subjects
- Astrocytoma immunology, Brain Neoplasms immunology, Cell Division, Evaluation Studies as Topic, Humans, Ki-67 Antigen, Paraffin Embedding, Predictive Value of Tests, Prognosis, S Phase, Sensitivity and Specificity, Astrocytoma mortality, Brain Neoplasms mortality, Flow Cytometry, Image Interpretation, Computer-Assisted, Immunohistochemistry, Neoplasm Proteins analysis, Nuclear Proteins analysis, Proliferating Cell Nuclear Antigen analysis
- Abstract
The prognostic power of three proliferation estimation methods, Ki-67 (MIB-1) and PCNA immunohistochemistry, and flow cytometry (S-phase and S + G2/M fractions, respectively), were evaluated in 50 cases of astrocytoma. Each proliferation index showed a strong association with the grade of malignancy (grades I-IV). The MIB-1 labelling index (LI) provided additional information, as it could be used for the discrimination of grade II and grade III astrocytomas (P = 0.0357). All three proliferation estimation methods also had strong prognostic potential (MIB-1 LI: P < 0.0001; PCNA Li: P < 0.0001; S-phase: P = 0.0004; S + G2/M: P = 0.0124). According to the receiver operating characteristics (ROC) curve, the MIB-1 LI showed generally the best sensitivity and specificity in placing the patients correctly into groups of survivors and non-survivors, which was further confirmed in the multivariate analysis. Only 4 per cent of the patients having high MIB-1 scores (> 15.3 per cent) were alive after 2-years' follow-up. In contrast, 72 per cent of patients with tumours of low proliferation activity survived. It appears that Ki-67 (MIB-1) immunolabelling using archival paraffin-embedded samples is of value in predicting prognosis in astrocytic tumours.
- Published
- 1994
- Full Text
- View/download PDF
25. Prognostic value of cells with more than 5c DNA content in node-negative breast cancer as determined by image cytometry from tissue sections.
- Author
-
Siitonen SM, Kallioniemi OP, Helin HJ, and Isola JJ
- Subjects
- Adult, Aged, Aged, 80 and over, Axilla, Breast Neoplasms genetics, Breast Neoplasms mortality, Breast Neoplasms pathology, Female, Flow Cytometry, Humans, Lymphatic Metastasis, Middle Aged, Ploidies, Prognosis, Survival Rate, Biomarkers, Tumor analysis, Breast Neoplasms diagnosis, DNA, Neoplasm analysis, Image Processing, Computer-Assisted
- Abstract
The aim of this investigation was to study the prognostic significance of 5c cells (presence of cancer cells with > 5c DNA content; ie, over 18 pg of DNA per nucleus) in axillary node-negative breast cancer. Tissue sections (3 microns) from 134 tumors were stained for DNA using the Feulgen method and screened for the percentage of 5c cells with the CAS 200 image analysis system (Cell Analysis System, Inc, Lombard, IL). Cancer cells with a DNA content exceeding the 5c level were found in 45% (60 of 134) of the cases, accounting for a median of 0.2% (range, 0.05% to 1.05%) of all cells. The presence of 5c cells was associated with a high histologic grade of the tumor (P = .0001), a large number of mitoses (P < .0001), flow cytometric DNA aneuploidy and high S-phase fraction (P = .0002 and P < .0001, respectively), and c-erbB-2 oncoprotein and p53 tumor suppressor gene product overexpression (P = .0002 and P = .0006, respectively). Patients with 5c cell-positive tumors had a significantly worse 8-year survival rate (P = .003) than those with 5c cell-negative tumors. Subgroup analysis showed that the presence of 5c cells had a prognostic impact in low malignancy tumors, ie, in well-differentiated (grade I or II) and slowly proliferating tumors. Our findings suggest that determination of 5c cells may be a useful additional prognostic factor in axillary node-negative breast cancer. It adds prognostic information, especially in cases that are otherwise thought to have a favorable course.
- Published
- 1993
- Full Text
- View/download PDF
26. Comparison of three quantitation methods for PCNA immunostaining: applicability and relation to survival in 83 astrocytic neoplasms.
- Author
-
Haapasalo HK, Sallinen PK, Helén PT, Rantala IS, Helin HJ, and Isola JJ
- Subjects
- Astrocytoma mortality, Biomarkers, Tumor analysis, Brain Neoplasms mortality, Cell Count, Glioblastoma pathology, Humans, Immunohistochemistry, Mitotic Index, Prognosis, Proliferating Cell Nuclear Antigen, Astrocytoma pathology, Autoantigens analysis, Brain Neoplasms pathology, Nuclear Proteins analysis
- Abstract
Recent studies on astrocytic tumours demonstrated a close association between patient prognosis and neoplastic proliferation estimated by such methods as Ki-67 and bromodeoxyuridine labelling. Novel monoclonal PCNA antibodies and special antigen-retrieval techniques have the advantage of working on routinely fixed and embedded specimens and thus make the estimation of proliferation simpler. In addition to PCNA-positive cell count expressed in percentages (PCNA-LI), we estimated the number of PCNA-immunopositive cells count expressed in percentages (PCNA-LI), we estimated the number of PCNA-immunopositive cells of 83 astrocytomas in two ways: (1) per mm2 of neoplastic tissue (uncorrected PCNA index); and (2) per mm2 of total neoplastic nuclear area (corrected PCNA index). Both of these methods were reproducible and showed a good correlation with PCNA-LI and malignancy grade (I-IV). With quantitation methods 1 and 2, the proliferative status of about 2000 cells could be estimated in about 7-10 min, whereas the PCNA count by PCNA-LI of 200 cells took approximately the same time. The proliferation indices obtained by all three quantitation methods were highly significantly related to patient prognosis. The corrected PCNA index, having a close association with the neoplastic cellularity, even divided the glioblastoma group (grade IV) into two significantly different prognostic groups in which 56 and 17 per cent of the patients were alive after 1-year follow-up. The combination of PCNA immunohistochemistry and morphometry seems to give important prognostic information about astrocytomas independent of the histopathological grade.
- Published
- 1993
- Full Text
- View/download PDF
27. Intratumor variation in cell proliferation in breast carcinoma as determined by antiproliferating cell nuclear antigen monoclonal antibody and automated image analysis.
- Author
-
Siitonen SM, Isola JJ, Rantala IS, and Helin HJ
- Subjects
- Adult, Aged, Aged, 80 and over, Breast Neoplasms immunology, Cell Division immunology, Female, Flow Cytometry, Humans, Image Processing, Computer-Assisted, Immunoenzyme Techniques, Kinetics, Middle Aged, Proliferating Cell Nuclear Antigen, Regression Analysis, S Phase immunology, Antibodies, Monoclonal, Breast Neoplasms pathology, Nuclear Proteins analysis
- Abstract
Immunohistochemical detection of the proliferating cell nuclear antigen (PCNA) represents a potentially useful tool for the study of tumor proliferative activity. To study the intratumor heterogeneity of tumor growth, 88 breast carcinomas were immunostained with the anti-PCNA antibody 19F4 and analyzed with the CAS 200 image analysis system (Cell Analysis System, Inc., Lombard, IL). For each sample, 12 fields from both the central and the peripheral areas of the tumor were measured. The proportion of PCNA-positive nuclear area in the whole tumor (PCNAt score) varied from 0.7% to 45.2% (median, 14.4%). There was considerable intratumor heterogeneity in the staining for PCNA. In 79% of the specimens, the PCNA score was higher in peripheral areas than in the center of the tumor, the average difference being +3.4% (range, -9.2- +15.1%; P < 0.0001, Student's t-test). The S-phase fraction, determined by DNA flow cytometry of the same tumors, varied from 2.0% to 32.6% (median, 10.0%). The PCNA score showed a significant correlation with the S-phase fraction (r = 0.469, P < 0.001). Most divergent results were those with high PCNA scores and low S-phase fraction; possible explanations for this are discussed. The PCNA score also was related to the histologic grade of the tumors (P = 0.03, analysis of variance). In conclusion, proliferation indices obtained from different areas of a tumor can differ significantly because of intratumor heterogeneity in growth fractions. The PCNA immunostaining correlates with well-known prognostic factors (S-phase fraction and histologic tumor grade) in breast carcinoma.
- Published
- 1993
- Full Text
- View/download PDF
28. IgA-IgM nephropathy. A subgroup of primary mesangial glomerulonephritis.
- Author
-
Mustonen JT, Rantala IS, Helin HJ, and Pasternack AI
- Subjects
- Adolescent, Biopsy, Female, Fluorescent Antibody Technique, Glomerulonephritis metabolism, Glomerulonephritis, IGA metabolism, Humans, Immunoglobulin A metabolism, Kidney metabolism, Kidney pathology, Kidney ultrastructure, Male, Microscopy, Electron, Middle Aged, Glomerulonephritis pathology, Glomerulonephritis, IGA pathology, Immunoglobulin M metabolism
- Abstract
The renal biopsy material of Tampere University Central Hospital comprises 1992 renal biopsy specimens, accessioned during the years 1978-1989. Among these, there were three cases of mesangial glomerulonephritis with a peculiar type of immunofluorescent reactivity. Striking mesangial deposits of both IgA and IgM were found in glomeruli, whereas C3 deposits were absent or present in slight amounts. The light microscopic findings ranged from mild mesangial glomerulonephritis to more advanced forms of sclerosing glomerulopathy. Electron microscopic examination disclosed an increase of mesangial matrix, together with mesangial and paramesangial electron-dense deposits. Two of the patients had microscopic hematuria associated with proteinuria, and one had isolated proteinuria. The authors propose that this group of cases may represent a new subgroup of primary mesangial glomerulonephritis that has not been described previously. They differ immunohistologically from both IgA nephropathy and IgM nephropathy, and therefore could be designated as IgA-IgM nephropathy.
- Published
- 1991
- Full Text
- View/download PDF
29. Immunocytochemical detection of progesterone receptor in breast carcinoma. Comparison of two monoclonal antibodies.
- Author
-
Isola JJ, Helle MJ, and Helin HJ
- Subjects
- Adult, Aged, Aged, 80 and over, Breast Neoplasms pathology, Charcoal, Evaluation Studies as Topic, Female, Humans, Immunoenzyme Techniques, Middle Aged, Staining and Labeling, Antibodies, Monoclonal, Breast Neoplasms analysis, Epitopes analysis, Receptors, Progesterone analysis
- Abstract
Immunocytochemical progesterone receptor (PR) assays employing two different monoclonal antireceptor antibodies (mPRi, JZB39) were compared with each other and with the dextran-coated charcoal assay (DCC) in human breast carcinoma. The immunocytochemical analyses were semiquantitatively scored (histoscore) based on relative staining intensity and the percentage of positively stained carcinoma cell nuclei. The immunocytochemically determined PR status agreed with that obtained by the DCC assay in 76% of the cases when the monoclonal antibody mPRi was used. The agreement was slightly better (82%) with the immunocytochemical assay using the JZB39 antibody. The semiquantitative histoscores correlated significantly with log-transformed cytosol PR concentrations in the DCC assay (mPRi, R = 0.543; JZB39, R = 0.618; P less than 0.0001 for both). The histoscores obtained with the mPRi and JZB39 antibodies were highly correlated with each other in adjacent frozen sections (R = 0.84, P less than 0.0001) the latter antibody giving somewhat higher histoscores. These results further validate the use of immunocytochemical PR assays for routine diagnostic purposes, especially when sufficient material is not available for DCC assays.
- Published
- 1990
- Full Text
- View/download PDF
30. Immunocytochemical detection of estrogen and progesterone receptors in 124 human breast cancers.
- Author
-
Helin HJ, Helle MJ, Helin ML, and Isola JJ
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Immunochemistry, Menopause, Methods, Middle Aged, Staining and Labeling, Breast Neoplasms analysis, Receptors, Estrogen analysis, Receptors, Progesterone analysis
- Abstract
Monoclonal antibodies to human estrogen receptor (ER), and rabbit progesterone receptor (PR), also recognizing human PR, were used to detect the receptors by peroxidase immunocytochemistry in frozen sections of 124 primary breast carcinomas. Both ER and PR were almost exclusively located in carcinoma cell nuclei, with heterogeneous distribution and intensity. The staining results were evaluated semiquantitatively (histoscore), based on the percentage of positively stained carcinoma cells and nuclear staining intensity. The receptor status thus determined was as follows: ER+PR+ in 50 patients, ER+PR- in 23, ER-PR- in 26, and ER-PR+ in 3 patients. There was a 79% (ER) or 70% (PR) agreement in the positivity/negativity between the immunocytochemical and steroid-binding assay (in 102 patients) with a highly significant correlation. The histoscore values increased significantly with cytosol receptor levels (ER, r = 0.623, P less than 0.001; PR, r = 0.366, P less than 0.01).
- Published
- 1988
- Full Text
- View/download PDF
31. Proliferative activity and steroid receptors determined by immunohistochemistry in adjacent frozen sections of 102 breast carcinomas.
- Author
-
Helin ML, Helle MJ, Helin HJ, and Isola JJ
- Subjects
- Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Breast Neoplasms metabolism, Carcinoma metabolism, Cell Division, Female, Freezing, Histological Techniques, Humans, Immunoenzyme Techniques, Middle Aged, Breast Neoplasms pathology, Carcinoma pathology, Receptors, Estrogen metabolism, Receptors, Progesterone metabolism
- Abstract
Adjacent frozen sections of 102 consecutive female breast carcinomas were examined for the expression of the Ki-67 antibody-reactive proliferation-associated nuclear antigen and of estrogen and progesterone receptors with the use of monoclonal antibodies and peroxidase histochemistry. The results of steroid receptor stainings were semiquantitatively assessed (histoscore) on the basis of nuclear staining intensity and the percentage of positively stained carcinoma cell nuclei. Carcinomas negative for either receptor had significantly higher percentages of Ki-67-positive cells. The highest percentages of Ki-67-positive cells were observed in carcinomas negative for both estrogen and progesterone receptors. There was a highly significant decrease in receptor histoscores with increasing proliferative cell fractions as determined by Ki-67 positivity. No significant (progesterone receptor) or poor negative correlation (estrogen receptor) was observed when proliferative cell fractions were related to receptor concentrations from conventional steroid-binding assays. Immunoperoxidase staining for the Ki-67 antibody-defined proliferation antigen and steroid receptors in tissue sections provides a simple means to gain information of therapeutic and prognostic importance.
- Published
- 1989
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.